XML 25 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Balance Sheets - USD ($)
$ in Millions
Oct. 29, 2023
Oct. 30, 2022
Current assets:    
Cash and cash equivalents $ 6,132 $ 1,995
Short-term investments 737 586
Accounts receivable, net 5,165 6,068
Inventories 5,725 5,932
Other current assets 1,388 1,344
Total current assets 19,147 15,925
Long-term investments 2,281 1,980
Property, plant and equipment, net 2,723 2,307
Goodwill 3,732 3,700
Purchased technology and other intangible assets, net 294 339
Deferred income taxes and other assets 2,552 2,475
Total assets 30,729 26,726
Current liabilities:    
Short-term debt 100 0
Accounts payable and accrued expenses 4,297 4,237
Contract liabilities 2,975 3,142
Total current liabilities 7,372 7,379
Long-term debt 5,461 5,457
Income taxes payable 833 964
Other liabilities 714 732
Total liabilities 14,380 14,532
Commitments and contingencies (Note 15)
Stockholders’ equity:    
Preferred stock: $0.01 par value per share; 1 shares authorized; no shares issued 0 0
Common stock: $0.01 par value per share; 2,500 shares authorized; 833 and 844 shares outstanding at 2023 and 2022, respectively 8 8
Additional paid-in capital 9,131 8,593
Retained earnings 43,726 37,892
Treasury stock: 1,191 and 1,173 shares at 2023 and 2022, respectively (36,299) (34,097)
Accumulated other comprehensive loss (217) (202)
Total stockholders’ equity 16,349 12,194
Total liabilities and stockholders’ equity $ 30,729 $ 26,726